SAN FRANCISCO–(BUSINESS WIRE)–Savonix,
a global leader in digital tests for cognitive health, announced today
that the Company will be presenting at the upcoming conferences:
International
Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2019
Dr. Mylea Charvat, CEO and Founder of Savonix will be speaking at the
following conferences:
Global
CEO Initiative on Alzheimer’s Disease (CEOi) and Ministry of
Economy, Trade and Industry of Japan (METI) Roundtable Discussion on
Brain Health
Global
Insurtech Leaders Summit
GENTRY
Women in Tech Conference 2019
Geodesic
Capital Annual Meeting (closed to press)
About Savonix
Savonix delivers a fully mobile assessment of cognitive function
available on Android and iOS for phone and tablet, the Savonix Cognitive
Assessment platform is an accurate, accessible and affordable tool for
professional cognitive screens. It empowers healthcare providers, payers
and researchers to evaluate and leverage results to improve health and
treatment outcomes. Led by clinical neuropsychologists and digital
health technology experts, the company has established itself as an
authority on cognition globally. To learn more about Savonix, visit Savonix.com.
Contacts
Savonix
Kimberly Ha
KKH Advisors
kimberly.ha@kkhadvisors.com
917-291-5744
London, United Kingdom--(Newsfile Corp. - April 15, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or…
SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a…
Situated at the junction of Broadway and Beacon, Sterling Urgent Care stands ready to deliver…
TORONTO, ON / ACCESSWIRE / April 15, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"),…
STOCKHOLM, SWEDEN / ACCESSWIRE / April 15, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB…
Charles W. Lapp, MD Charles W. Lapp, MD OCALA, Fla., April 15, 2024 (GLOBE NEWSWIRE)…